Inhibition of MiR-205 Impairs the Wound-healing Process in Human Corneal Epithelial Cells by Targeting KIR4.1 (KCNJ10)
Overview
Affiliations
Purpose: The aim of the study was to test the hypotheses that injury stimulates the expression of miR-205, which in turn inhibits KCNJ10 channels by targeting its 3' UTR, thereby facilitating the wound-healing process in human corneal epithelial cells (HCECs).
Methods: A stem-loop qRT-PCR was used to examine the miR-205 expression. BrdU cell proliferation assay and wound scratch assay were applied to measure the effect of miR-205 mimic or antagomer in HCECs. The patch-clamp technique, dual luciferase reporter assay, and Western blot analysis were employed to test whether miR-205 regulates KCNJ10, one of the target genes of miR-205. Both of the primary human and mouse corneal epithelial cells (pH/MCECs) were employed to further confirm the observations obtained in HCECs.
Results: The scratch injury in pH/MCECs increased the expression of miR-205 and decreased the expression of KCNJ10 within 24 hours. The notion that miR-205 may target KCNJ10 was supported by dual luciferase reporter assay showing an inhibition effect of miR-205 on 3' UTR of KCNJ10. Application of miR-205 antagomer significantly delayed the regrowth in wounded HCECs. However, inhibition of KCNJ10 partially abolished the effect from miR-205 antagomer and restored the healing process. Moreover, overexpression miR-205 antagomer enhanced the protein expression of KCNJ10 but not KCNJ16. In addition, patch-clamp demonstrated that inhibition of endogenous miR-205 expression increased Ba²⁺-sensitive inwardly rectifying K⁺ channels. In addition, an electrophysiological study of pHCECs showed the presence of KCNJ10-like 20 pS K⁺ channels and scratch injury significantly decreased the Ba²⁺-sensitive inwardly rectifying K⁺ currents.
Conclusions: miR-205 stimulates wound healing by inhibiting its target gene KCNJ10.
miRNA Expression Profile in Primary Limbal Epithelial Cells of Aniridia Patients.
Nastaranpour M, Suiwal S, Stachon T, Fries F, Amini M, Seitz B Invest Ophthalmol Vis Sci. 2025; 66(1):20.
PMID: 39786759 PMC: 11725988. DOI: 10.1167/iovs.66.1.20.
Exosomal microRNAs as potential biomarkers and therapeutic targets in corneal diseases.
Arora S, Verma N Mol Vis. 2024; 30:92-106.
PMID: 38601014 PMC: 11006010.
Limbal Epithelial Stem Cells in the Diabetic Cornea.
Nureen L, Di Girolamo N Cells. 2023; 12(20).
PMID: 37887302 PMC: 10605319. DOI: 10.3390/cells12202458.
Mesenchymal Stromal Cell-Based Therapy for Dry Eye: Current Status and Future Perspectives.
Jiang Y, Lin S, Gao Y Cell Transplant. 2022; 31:9636897221133818.
PMID: 36398793 PMC: 9679336. DOI: 10.1177/09636897221133818.
Corneal Epithelial Regeneration: Old and New Perspectives.
Nuzzi A, Pozzo Giuffrida F, Luccarelli S, Nucci P Int J Mol Sci. 2022; 23(21).
PMID: 36361918 PMC: 9655297. DOI: 10.3390/ijms232113114.